title: Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.
abstract: This article discusses the measurement of cognition in schizophrenia, its role as a determinant of disability, and treatment efforts to date, including pharmacological and behavioral interventions as well as effective treatments that lead to improved outcomes. The measurement of functioning when patients with schizophrenia receive treatment in the office is addressed. The review focuses on new developments in the creation and adoption of a consensus method for the assessment of cognitive functioning in treatment studies, on the increased appreciation for assessment of functional skills in the prediction of everyday outcomes, and on developments in the basic neuroscience of cognition.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120 North West 14th Street, Suite 1450, Miami, FL 33136, USA. philipdharvey1@cs.com
authors.forename: Philip D
authors.initials: PD
authors.lastname: Harvey
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Bowie
mesh_terms: D001521:Behavior Therapy / Q000379:methods*; D003072:Cognition Disorders / Q000209:etiology / Q000628:therapy*; D006801:Humans; D018697:Nootropic Agents / Q000627:therapeutic use*; D012559:Schizophrenia / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents